Navigation Links
Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
Date:3/5/2008

and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify brain oxygen imbalances and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit http://www.somanetics.com.


'/>"/>
SOURCE Somanetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
2. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
4. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
5. Met-Pro Corporations Systems Division Receives Equipment Order Totaling Approximately $600,000
6. Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing
7. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
8. Senior Lifestyle Corporation Names John Cobb as President and CEO
9. Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes
10. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
11. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... ORSupply.com expands its selection o... to include full diagnostic product lines from Lit...ille, KY (Vocus) December 3, 2008 -- Littmann and ...ORSupply.com, the Internet’s largest marketp... adding Littman and Heine stethoscopes to its onli...
(Date:12/2/2008)...reast-specific gamma imaging (BSGI) is effective i... or by clinical exam, according to a study present... Society of North America (RSNA). , "BSGI can id...nvasive lobular carcinoma," said lead author Rache...or of the Breast Imaging and Interventional Center...
(Date:12/2/2008).... 3 Minimally invasive,...thod for removal of self-inflicted,foreign object..."self-,embedding disorder," or self-injury and se...s. The findings will be presented today at the ann...America (RSNA). , "Radiologists are in a un...
(Date:12/2/2008)...ANCISCO, Calif., Dec. 1 diaDexus, ...roval for the automated format of the,PLAC Test f...est, capable of,running on a wide range of clinic....S. Food & Drug Administration (FDA) in Decemb...nt of the CE Marked PLAC Test to Europe. , ...
Breaking Medicine News(10 mins):Health News:Littmann and Heine Stethoscopes Now Available from ORSupply.com 2Health News:Littmann and Heine Stethoscopes Now Available from ORSupply.com 3Health News:New breast imaging technology targets hard-to-detect cancers 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 3Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2
...nsurance plans show wide variations among differen...premium dollar. // -Employees in the smallest fir... insurance premiums than those in the largest firm...--the percentage of total medical expenses paid by...
...egulatory body is set up by the Indian information...ter the theft of data, by 3 employees of a BPO fir... in the IT industry. The move is to bolster overse... of instances have stirred the IT sector to set up...
...ptive pill, Dianette also used to treat acne, has ...rities after concerns were expressed about its lin...ntraceptive that was licensed as a hormone treatme...r review when over 100 women said they suffered de...
...n Ilhan tenderly kissed his 2-year-old daughter, J... as he kissed Jaida, he noticed that her face bega... whether it was caused by something she ate or som...t it was me,' he recalled. 'I ate some peanuts tha...
Other Medicine News:Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3Health News:Allergic to Kisses? 2
(Date:12/2/2008)..., Kan., Dec. 2 IBT Laboratories, a...arch laboratory specializing in immunology and all...ests to evaluate the response of patients whose i...immunodeficiency disorder, chemotherapy drugs, or ...o prevent rejection of a transplant. The company l...
(Date:12/1/2008)...O, Dec. 2 New research ...t-slice computed tomography (CT) scanner in an eme...of stroke victims who receive a potentially life-s...t North Shore Medical Center (NSMC)-Salem Hospital...nnual meeting of the Radiological Society of North...
(Date:12/1/2008)...ORE, Dec. 1 S*BIO Pte Ltd today an...al of SB1518, a potent and orally-active JAK2 inhi... patients with chronic idiopathic myelofibrosis (C...e the safety and tolerability of SB1518 in patient...ents. The Phase 1 part of the study will assess t...
(Date:12/1/2008)...Abstinence is still the best policy , , RO...A new study from Mayo Clinic finds the use of the ...coholic hepatitis, an acute inflammation of the li...e results of the study are published in the Decemb...journal.org/ ). , , VIDEO ALERT: Additiona...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 1China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 2Strategies to control TB outdated inadequate 24851 1Strategies to control TB outdated inadequate 24851 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 1HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 2HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 3
...Sciences, Inc.,(Nasdaq:GILD) today announced detai...ing aztreonam lysine for inhalation, an,antibiotic...ulmonary Pseudomonas aeruginosa (P. aeruginosa). I...m lysine significantly improved,the time to need f...placebo. All patients received an initial 28 days ...
...x Pharmaceuticals,Inc. (OTCBB:CGXP), a biopharmac...dermatology, today announced the publication,of a ...al,compounds: CSA-8 and CSA-13. The paper appeared...l Agents and Chemotherapy, a,peer-reviewed officia... dedicated to advances in the field of applied,mic...
Other Medicine Technology:Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator.
VersaStep™ Reposable Sterilization Trays.
VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures., ,The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has
...ade; Blunt Tip Trocar consists of a blunt obturato... , ,The valve body assembly contains an internal ... instruments are inserted or withdrawn. The Autosu...verters to allow insertion of instruments of diffe...
Medicine Products: